Wednesday, July 6, 2022
Home Authors Posts by Editor / Curator

Editor / Curator

613 POSTS 0 COMMENTS
Client

Smart for Life (SMFL) Capitulates?

Editor / Curator -
Biotech News

Althira (ATHA) $2.50, is Latest Alzheimer’s Trial Victim. Down 70%

Editor / Curator -
Bitcoin

Novogratz Remains Steadfast on Crypto, Says Wait Until Next Year (Bloomberg)

Editor / Curator -
ehave
All News

Ehave, Inc. Announces its KetaDASH Mobile Unit Delivered to Miami Beach.

Editor / Curator -
Roland Rick Perry
Stand Down

Bidenflation Hits Delray Beach Bars Hard.

Editor / Curator -
All News

Nightmare on Crypto Street.

Editor / Curator -
All News

Smart for Life (SMFL) $0.43 on Track to Close Pending Acquisition...

Editor / Curator -
Stand Down

1.9 Trillion Trades on OTCMarkets in May. Thumbs up or Buyer...

Editor / Curator -
Superbug News - CoronaVirus Watch List

Revive’s Quarterly Report, Discussion, and a Video!

Editor / Curator -
Revive Therapeutics
Superbug News - CoronaVirus Watch List

Revive Therapeutics Gains 25% on Positive FDA Comments.

Editor / Curator -
123...62Page 1 of 62

Latest article

Smart for Life (SMFL) Capitulates?

Client Editor / Curator -
We Are Long Term Bullish on Smart for Life. After a Volatile Post IPO Trading, we may Have Seen the Bottom....

Althira (ATHA) $2.50, is Latest Alzheimer’s Trial Victim. Down 70%

Biotech News Editor / Curator -
Nearly 100 Alzheimer’s programs have failed in the past decade. Biotech investors should study or at least become...

Novogratz Remains Steadfast on Crypto, Says Wait Until Next Year (Bloomberg)

Bitcoin Editor / Curator -
Great call. This was actually from Late 2018. (Bloomberg) — Billionaire investor Michael Novogratz is resolute when it...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: roland@institutionalanalyst.com
© Managed by Revelers.IO Media Group Inc.